← SynDRA
MUBRITINIB
SynDRA canonical compound SYN0025685 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EGFR | ERBB2 |
|---|
| Mechanism of action | protein tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- tyrosine kinase inhibitor
- EGFR INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- MINK1
- SYK
- AAK1
- NTRK1
- PIM2
- PIM1
- PHKG2
- PGRMC1
- PFKP
- PEBP1
- PDXK
- PDGFRB
- PASK
- PAK4
- PAK2
- PAICS
- OPA1
- PIP4K2C
- PKMYT1
- PKN1
- PRKAG2
- PRKCQ
- PRKCI
- PRKCD
- PRKCB
- PRKCA
- PRKAR2A
- PRKAG1
- PKN2
- PRKACG
- PRKACB
- PRKACA
- PRKAA1
- PLK4
- PLK1
- NUAK2
- NME2
- NQO2
- MAPK9
- MCM4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- TAK-165
- TAK165
- TAK 165
- Mubritinib (USAN/INN)
- 4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole
- Mubritinib (TAK 165)
- (E)-4-((4-(4-(1H-1,2,3-triazol-1-yl)butyl)phenoxy)methyl)-2-(4-(trifluoromethyl)styryl)oxazole
- V734AZP9BR
- 1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
- 1-(4-(4-((2-((E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)oxazol-4-yl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
- 1H-1,2,3-triazole, 1-(4-(4-((2-((1E)-2-(4-(trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-
- Mubritinib [USAN]
- Mubritinib [USAN:INN]
- UNII-V734AZP9BR
- (E)-4-[[4-[4-(1H-1,2,3-Triazol-1-yl)butyl]phenoxy]methyl]-2-[4-(trifluoromethyl)styryl]oxazole
- 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole
- 1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
- 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
- 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
- Mubritinib;TAK-165
- Mubritinib; TAK-165
- MUBRITINIB [INN]
- Mubritinib - TAK 165
- SCHEMBL94943
- MUBRITINIB, FREE BASE
- MLS006010161
- GTPL6011
- CHEMBL1614707
- Mubritinib, >=98% (HPLC)
- DTXSID501026014
- HMS3414A21
- HMS3678A21
- BCP02837
- EX-A2107
- MFCD09954135
- NSC800802
- s2216
- ZINC11679877
- AKOS015918001
Look up MUBRITINIB in the interactive SynDRA portal →